Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress

Psychoneuroendocrinology

Volumn 38, Issue 6, 2013, Pages 898-906

  Tran, L ^b   Chaloner, A ^b   Sawalha, A H ^d   Greenwood Van Meerveld, B ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amygdala; Corticotropin releasing factor; Epigenetics; Glucocorticoid receptor; Irritable bowel syndrome

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; TRICHOSTATIN A;

ABDOMINAL WALL MUSCULATURE; ADULT; ADULT ANIMAL; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC STRESS; CHRONIC WATER AVOIDANCE STRESS; COLON; CONTROLLED STUDY; CORTICOTROPIN RELEASING FACTOR GENE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GLUCOCORTICOID RECEPTOR GENE; HUMAN; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; RAT; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VISCERAL PAIN;

AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; INFUSIONS, INTRAVENTRICULAR; MALE; PAIN MEASUREMENT; RATS; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL; VISCERAL PAIN;

EID: 84877078103     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.09.016     Document Type: Article

References (54)

1. Blanchard E.B., Lackner J.M., Jaccard J., Rowell D., Carosella A.M., Powell C., Sanders K., Krasner S., Kuhn E. The role of stress in symptom exacerbation among IBS patients. J. Psychosom. Res. 2008, 64:119-128.
2. Bradesi S., Schwetz I., Ennes H.S., Lamy C.M., Ohning G., Fanselow M., Pothoulakis C., McRoberts J.A., Mayer E.A. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G42-G53.
3. Burnstein K.L., Jewell C.M., Cidlowski J.A. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J. Biol. Chem. 1990, 265:7284-7291.
4. Burnstein K.L., Bellingham D.L., Jewell C.M., Powell-Oliver F.E., Cidlowski J.A. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991, 56:52-58.
5. Chang L., Sundaresh S., Elliott J., Anton P.A., Baldi P., Licudine A., Mayer M., Vuong T., Hirano M., Naliboff B.D., Ameen V.Z., Mayer E.A. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol. Motil. 2009, 21:149-159.
6. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 1986, 6:2908-2914.
7. Chen J., Evans A.N., Liu Y., Honda M., Saavedra J.M., Aguilera G. Maternal deprivation in rats is associated with corticotropin releasing hormone (CRH) promoter hypomethylation and enhances CRH transcriptional responses to stress in adulthood. J. Neuroendocrinol. 2012, 24:1055-1064.
8. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., O'Mahony S., Shanahan F., Keeling P.W. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
9. Elliott E., Ezra-Nevo G., Regev L., Neufeld-Cohen A., Chen A. Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nat. Neurosci. 2010, 13:1351-1353.
10. Gosselin R.D., O'Connor R.M., Tramullas M., Julio-Pieper M., Dinan T.G., Cryan J.F. Riluzole normalizes early life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms. Gastroenterology 2010, 138:2418-2425.
11. Greenwood-Van Meerveld B., Johnson A.C., Cochrane S., Schulkin J., Myers D.A. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol. Motil. 2005, 17:415-422.
12. Greenwood-Van Meerveld B., Gibson M., Gunter W., Shepard J., Foreman R., Myers D. Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res. 2001, 893:135-142.
13. Hughes T., Webb R., Fei Y., Wren J.D., Sawalha A.H. DNA methylome in human CD4+ T cells identifies transcriptionally repressive and non-repressive methylation peaks. Genes Immun. 2010, 11:554-560.
14. Jeanneteau F.D., Lambert W.M., Ismaili N., Bath K.G., Lee F.S., Garabedian M.J., Chao M.V. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1305-1310.
15. Ji G., Neugebauer V. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J. Neurophysiol. 2008, 99:1201-1212.
16. Larauche M., Mulak A., Tache Y. Stress and visceral pain: from animal models to clinical therapies. Exp. Neurol. 2012, 233:29-67.
17. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
18. Lydiard R.B. Irritable bowel syndrome, anxiety, and depression: what are the links?. J. Clin. Psychiatry 2001, 62(Suppl. 8):38-45.
19. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 1994, 640:105-112.
20. Makino S., Gold P.W., Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 1994, 657:141-149.
21. Makino S., Smith M.A., Gold P.W. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res. 2002, 943:216-223.
22. Malkoski S.P., Handanos C.M., Dorin R.I. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol. Cell. Endocrinol. 1997, 127:189-199.
23. Mayer E.A., Aziz Q., Coen S., Kern M., Labus J.S., Lane R., Kuo B., Naliboff B., Tracey I. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol. Motil. 2009, 21:579-596.
24. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
25. Meaney M.J., Sapolsky R.M., McEwen B.S. The development of the glucocorticoid receptor system in the rat limbic brain. I. Ontogeny and autoregulation. Brain Res. 1985, 350:159-164.
26. Meng Q.Y., Chen X.N., Tong D.L., Zhou J.N. Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex. Mol. Cell. Endocrinol. 2011, 342:54-63.
27. Minetti G.C., Colussi C., Adami R., Serra C., Mozzetta C., Parente V., Fortuni S., Straino S., Sampaolesi M., Di Padova M., Illi B., Gallinari P., Steinkuhler C., Capogrossi M.C., Sartorelli V., Bottinelli R., Gaetano C., Puri P.L. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 2006, 12:1147-1150.
28. Moreira J.M., Scheipers P., Sorensen P. The histone deacetylase inhibitor trichostatin A modulates CD4+ T cell responses. BMC Cancer 2003, 3:30.
29. Myers B., Greenwood-Van Meerveld B. Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1622-G1629.
30. Myers B., Greenwood-Van Meerveld B. Elevated corticosterone in the amygdala leads to persistent increases in anxiety-like behavior and pain sensitivity. Behav. Brain Res. 2010, 214:465-469.
31. Myers B., Greenwood-Van Meerveld B. Differential involvement of amygdala corticosteroid receptors in visceral hyperalgesia following acute or repeated stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:6260-6266.
32. Myers B., Dittmeyer K., Greenwood-Van Meerveld B. Involvement of amygdaloid corticosterone in altered visceral and somatic sensation. Behav. Brain Res. 2007, 181:163-167.
33. Myers D.A., Gibson M., Schulkin J., Greenwood Van-Meerveld B. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav. Brain Res. 2005, 161:39-44.
34. Noguchi T., Makino S., Matsumoto R., Nakayama S., Nishiyama M., Terada Y., Hashimoto K. Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated immobilization stress. Endocrinology 2010, 151:4344-4355.
35. Patel P.D., Katz M., Karssen A.M., Lyons D.M. Stress-induced changes in corticosteroid receptor expression in primate hippocampus and prefrontal cortex. Psychoneuroendocrinology 2008, 33:360-367.
36. Posserud I., Agerforz P., Ekman R., Bjornsson E.S., Abrahamsson H., Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004, 53:1102-1108.
37. Razin A., Riggs A. DNA methylation and gene function. Science 1980, 210:604-610.
38. Sanderson L., Taylor G.W., Aboagye E.O., Alao J.P., Latigo J.R., Coombes R.C., Vigushin D.M. Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin A after intraperitoneal administration to mice. Drug Metab. Dispos. 2004, 32:1132-1138.
39. Shepard J.D., Barron K.W., Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res. 2000, 861:288-295.
40. Sterrenburg L., Gaszner B., Boerrigter J., Santbergen L., Bramini M., Elliott E., Chen A., Peeters B.W., Roubos E.W., Kozicz T. Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. PLoS One 2011, 6:e28128.
41. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 1989, 285:413-435.
42. Tache Y., Martinez V., Million M., Maillot C. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Eur. J. Surg. Suppl. 2002, 587:16-22.
43. Thompson B.L., Erickson K., Schulkin J., Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav. Brain Res. 2004, 149:209-215.
44. Tran L., Keele N.B. P-chlorophenylalanine increases glutamate receptor 1 transcription in rat amygdala. Neuroreport 2011, 22:758-761.
45. Usui T., Okada M., Mizuno W., Oda M., Ide N., Morita T., Hara Y., Yamawaki H. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:1894-1904.
46. Venkova K., Johnson A.C., Myers B., Greenwood-Van Meerveld B. Exposure of the amygdala to elevated levels of corticosterone alters colonic motility in response to acute psychological stress. Neuropharmacology 2010, 58:1161-1167.
47. Vigushin D.M., Ali S., Pace P.E., Mirsaidi N., Ito K., Adcock I., Coombes R.C. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res. 2001, 7:971-976.
48. Watts A.G., Sanchez-Watts G. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J. Physiol. 1995, 484:721-736.
49. Weaver I.C. Epigenetic effects of glucocorticoids. Semin. Fetal. Neonatal Med. 2009, 14:143-150.
50. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
51. Yao M., Denver R.J. Regulation of vertebrate corticotropin-releasing factor genes. Gen. Comp. Endocrinol. 2007, 153:200-216.
52. Yao M., Schulkin J., Denver R.J. Evolutionarily conserved glucocorticoid regulation of corticotropin-releasing factor expression. Endocrinology 2008, 149:2352-2360.
53. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 1990, 265:17174-17179.
54. Zhang L., Qin X., Zhao Y., Fast L., Zhuang S., Liu P., Cheng G., Zhao T.C. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J. Pharmacol. Exp. Ther. 2012, 341:285-293.